Menu
Recruiting NCT03992625

Clinical Outcomes for Deep Brain Stimulation

— Observational Parkinson Disease Essential Tremor Dystonia

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Deep Brain Stimulation.
Who it may be relevant to
Registry conditions: Parkinson Disease, Essential Tremor, Dystonia. Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Clinical Outcomes for Deep Brain Stimulation for Parkinson Disease, Tremor, and Dystonia

Overview

The object of this study is to longitudinally collect clinical outcomes of patients receiving deep brain stimulation for movement disorders with the objective of making retrospective comparisons and tracking of risks, benefits, and complications.

Interventions

  • Device Deep Brain Stimulation
    High frequency electrical stimulation of deep brain nuclei for the treatment of movement disorders

Primary outcome measures

  • UPDRS [Time frame: Change in UPDRS at 1 year after DBS (from preoperative baseline).]

Eligibility criteria

Inclusion criteria

  • Levodopa responsive Parkinson disease OR
  • Medically refractory Essential Tremor OR
  • Medically refractory Dystonia

Exclusion criteria

  • Dementia (Mattis Dementia Rating Scale <130)
  • Structural abnormalities precluding intracranial surgery

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Other

Study locations

United States · 1 center
  • Washington University in St Louis — St Louis

Identifiers

NCT: NCT03992625 · 201101744 · R01NS075321 · R01NS097437 · R21NS098020 · T32EB021955

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗